[HTML][HTML] An overview of current COVID-19 vaccine platforms

A Nagy, B Alhatlani - Computational and structural biotechnology journal, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the
coronavirus disease 2019 (COVID-19) pandemic that emerged in December 2019 in Wuhan …

Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases

S Wang, B Liang, W Wang, L Li, N Feng… - Signal transduction and …, 2023 - nature.com
Human diseases, particularly infectious diseases and cancers, pose unprecedented
challenges to public health security and the global economy. The development and …

[HTML][HTML] Vaccines for SARS-CoV-2: lessons from other coronavirus strains

E Padron-Regalado - Infectious diseases and therapy, 2020 - Springer
The emergence of the strain of coronavirus SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2) and its impact on global health have made imperative the …

Newcastle disease vaccines—A solved problem or a continuous challenge?

KM Dimitrov, CL Afonso, Q Yu, PJ Miller - Veterinary microbiology, 2017 - Elsevier
Newcastle disease (ND) has been defined by the World Organisation for Animal Health as
infection of poultry with virulent strains of Newcastle disease virus (NDV). Lesions affecting …

Advances in development and application of influenza vaccines

J Chen, J Wang, J Zhang, H Ly - Frontiers in immunology, 2021 - frontiersin.org
Influenza A virus is one of the most important zoonotic pathogens that can cause severe
symptoms and has the potential to cause high number of deaths and great economic loss …

Newcastle disease virus: current status and our understanding

K Ganar, M Das, S Sinha, S Kumar - Virus research, 2014 - Elsevier
Newcastle disease (ND) is one of the highly pathogenic viral diseases of avian species. ND
is economically significant because of the huge mortality and morbidity associated with it …

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate

W Sun, SR Leist, S McCroskery, Y Liu, S Slamanig… - …, 2020 - thelancet.com
Background Due to the lack of protective immunity of humans towards the newly emerged
SARS-CoV-2, this virus has caused a massive pandemic across the world resulting in …

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses

W Sun, Y Liu, F Amanat, I González-Domínguez… - Nature …, 2021 - nature.com
Rapid development of COVID-19 vaccines has helped mitigating SARS-CoV-2 spread, but
more equitable allocation of vaccines is necessary to limit the global impact of the COVID-19 …

A Newcastle disease virus (NDV) expressing a membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine

W Sun, S McCroskery, WC Liu, SR Leist, Y Liu… - Vaccines, 2020 - mdpi.com
A successful severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine must
not only be safe and protective, but must also meet the demand on a global scale at a low …

Vaccine candidates against coronavirus infections. Where does COVID-19 stand?

J Al-Kassmy, J Pedersen, G Kobinger - Viruses, 2020 - mdpi.com
Seven years after the Middle East respiratory syndrome (MERS) outbreak, a new severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) made its first appearance in a food …